Accessibility Menu
Alibaba Health Information Technology logo

Alibaba Health Information Technology(OTC) ALBHF

Current Price$0.43
Market Cap$6.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-58%
5 Year-76%
1 Year-30%
1 Month-2%
Alibaba Health Information Technology last closing stock price
MetricPriceDate
Last closeUSD 0.432026-07-24
Alibaba Health Information Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.38%USD 0.422026-07-06
1 month-2.27%USD 0.442026-06-23
3 month-27.1%USD 0.592026-04-23
Year to date-37.13%USD 0.682025-12-31
1 year-29.51%USD 0.612025-07-24
3 year-34.85%USD 0.662023-07-25
5 year-76.11%USD 1.802021-07-23
Since inception-58.25%USD 1.032018-07-20

Alibaba Health Information Technology Financials at a Glance

Market Cap

$6.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥58.21B

Net Income (TTM)

CN¥2.91B

EPS (TTM)

$0.02

P/E Ratio

25.60

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$0.43

Volume

500

Open

$0.43

Previous Close

$0.43

Daily Range

$0.43 - $0.43

52-Week Range

$0.40 - $0.90

Estimated Earnings Date

Dec 1, 2026

ALBHF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alibaba Health Information Technology

Alibaba Health Information Technology Limited is a leading investment holding company in the healthcare sector, operating primarily in Mainland China and Hong Kong. The company focuses on a diverse range of pharmaceutical and healthcare services, including direct pharmaceutical sales and digital healthcare offerings.

Products and Services
  • Direct pharmaceutical sales through online and physical outlets
  • Digital healthcare services, including medical consultations and health check-ups
  • Comprehensive e-commerce platform for health-related products
Growth Outlook
  • Revenue increased to CNY 17.14 billion in the latest quarter
  • Net income rose to CNY 653.6 million, reflecting strong operational efficiency
  • Operating income margin improved to 4.08%, indicating better cost management
Financial Highlights
  • Trailing twelve-month revenue of CNY 65.5 billion, showcasing consistent growth
  • Current ratio of 3.03, indicating strong liquidity position
  • Net profit margin of 5.65%, demonstrating effective profitability strategies
Alibaba Health Information Technology Limited has established itself as a significant player in the healthcare industry, leveraging technology to enhance service delivery. The company's diverse product offerings and robust e-commerce platform cater to a wide range of consumer needs, from pharmaceuticals to digital health services. Recent financial performance highlights a strong upward trend in revenue and profitability, suggesting effective management and operational strategies. The company's solid liquidity position further supports its ability to invest in growth opportunities and navigate market challenges. With a focus on innovation and customer-centric services, Alibaba Health is well-positioned for future growth in the evolving healthcare landscape.
AI Generated • Jul 4, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,394

CEO

Di Fan Shen

Website

www.alihealth.cn

Headquarters

Causeway Bay, HK

ALBHF Financials

Key Financial Metrics (TTM)

Gross Margin

23.97%

Operating Margin

5.36%

Net Income Margin

5.65%

Return on Equity

10.95%

Return on Capital

9.92%

Return on Assets

8.41%

Earnings Yield

3.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.13B

Volume

500

Avg. Volume

1.11K

Financials (TTM)

Gross Profit

CN¥13.92B

Operating Income

CN¥2.85B

EBITDA

CN¥3.24B

Operating Cash Flow

CN¥2.81B

Capital Expenditure

-CN¥4.36M

Free Cash Flow

CN¥2.80B

Cash & ST Invst.

CN¥10.44B

Total Debt

CN¥59.52M

Alibaba Health Information Technology Performance Analysis

Alibaba Health Information Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CNY 3,904,664,06421.8%
20242024-03-31CNY 3,771,123,496-3.4%
20252025-03-31CNY 4,238,964,08012.4%
20262026-03-31CNY 4,822,654,21113.8%
Alibaba Health Information Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31-42.8%
Q42025-03-31100.0%
Q22025-09-30N/A
Q42026-03-31N/A
Alibaba Health Information Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CNY 0.01N/A
20242024-03-31CNY 0.0150.0%
20252025-03-31CNY 0.0141.4%
20262026-03-31CNY 0.0236.6%
Alibaba Health Information Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31-57.1%
Q42025-03-31100.0%
Q22025-09-30N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CN¥17.14B

+20.1%

Gross Profit

CN¥3.93B

+11.2%

Gross Margin

22.93%

N/A

Market Cap

$6.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.85M

N/A

Employees

1,429

N/A

Net Income

CN¥653.62M

-15.0%

EBITDA

CN¥728.04M

-7.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CN¥10.44B

+35.0%

Total Debt

CN¥59.52M

-12.5%

Accounts Receivable

CN¥1.26B

-44.9%

Inventory

CN¥1.84B

+12.7%

Long Term Debt

CN¥30.06M

-25.9%

Short Term Debt

CN¥29.46M

+7.3%

Return on Assets

8.41%

N/A

Return on Invested Capital

10.24%

N/A

Free Cash Flow

CN¥787.55M

+40.9%

Operating Cash Flow

CN¥790.58M

+40.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHEOYCochlear Limited
$39.04+0.51%
BMXMFbioMérieux S.A.
$78.99+0.00%
FSPKFFisher & Paykel Healthcare Corporation Limited
$22.96+0.00%
SGIOYShionogi & Co., Ltd.
$8.68+0.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Questions About ALBHF

What is the current price of Alibaba Health Information Technology?

Alibaba Health Information Technology is trading at $0.43 per share.

What is the 52-week range for Alibaba Health Information Technology?

Over the past 52 weeks, Alibaba Health Information Technology has traded between $0.40 and $0.90.

How much debt does Alibaba Health Information Technology have?

As of the most recent reporting period, Alibaba Health Information Technology reported total debt of CN¥8.65M.

How much cash does Alibaba Health Information Technology have on hand?

Alibaba Health Information Technology reported CN¥832.76M in cash and cash equivalents in its most recent financial results.

What is Alibaba Health Information Technology’s dividend yield?

Alibaba Health Information Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services